Xiaolong Liu

Xiaolong Liu

Auto-generated profile, based on publicly available information

Xiaolong Liu

State Key Laboratory of Cell Biology, Chinese Academy of Sciences Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GXGang Xiao
Gang Xiao
ADAnqi Deng
Anqi Deng
HLHaifeng Liu
Haifeng Liu
GGGaoxiang Ge
Gaoxiang Ge
XLXiaolong Liu
Xiaolong Liu
T cells play a critical role in tumor immunosurveillance by eliminating newly transformed somatic cells. However, tumor cell variants can escape from immunological control after immunoediting, leading to tumor progression. Whether and how T cells respond to tumor growth remain unclear. Here, we found that tumor-infiltrating T cells exhibited persistently up-regulated expression of the activator protein 1 (AP-1) subunit c-Fos during tumor progression. The ectopic expression of c-Fos in T cells exacerbated tumor growth, whereas the T-cell–specific deletion of c-Fos reduced tumor malignancy. This unexpected immunosuppressive effect of c-Fos was mediated through the induced expression of immune inhibitory receptor programmed death 1 (PD-1) via the direct binding of c-Fos to the AP-1–binding site in the Pdcd1 (gene encoding PD-1) promoter. A knock-in mutation of this binding site abrogated PD-1 induction, augmented antitumor T-cell function and repressed tumor growth. Taken together, these findings indicate that T-cell c-Fos subsequently induces PD-1 expression in response to tumor progression and that disrupting such induction is essential for repression of tumor growth.

6 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
WBWenjie Bao
Wenjie Bao
HXHuayue Xing
Huayue Xing
SCShiwei Cao
Shiwei Cao
XLXin Long
Xin Long
HLHaifeng Liu
Haifeng Liu
XLXiaolong Liu
Xiaolong Liu
Disseminated intravascular coagulation (DIC) is a complication of sepsis currently lacking effective therapeutic options. Excessive inflammatory responses are emerging triggers of coagulopathy during sepsis, but the interplay between the immune system and coagulation are not fully understood. Here we utilize a murine model of intraperitoneal lipopolysaccharide stimulation and show neutrophils in the circulation mitigate the occurrence of DIC, preventing subsequent septic death. We show circulating neutrophils release extracellular vesicles containing mitochondria, which contain superoxide dismutase 2 upon exposure to lipopolysaccharide. Extracellular superoxide dismutase 2 is necessary to induce neutrophils’ antithrombotic function by preventing endothelial reactive oxygen species accumulation and alleviating endothelial dysfunction. Intervening endothelial reactive oxygen species accumulation by antioxidants significantly ameliorates disseminated intravascular coagulation improving survival in this murine model of lipopolysaccharide challenge. These findings reveal an interaction between neutrophils and vascular endothelium which critically regulate coagulation in a model of sepsis and may have potential implications for the management of disseminated intravascular coagulation.

22 December 2009 in Cell Research
Verified
Journal Article
Closed access
YCYonghao Cao
Yonghao Cao
HLHai Li
Hai Li
HLHaifeng Liu
Haifeng Liu
CZChao Zheng
Chao Zheng
HJHongbin Ji
Hongbin Ji
XLXiaolong Liu
Xiaolong Liu

12 September 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
XSXiang Sun
Xiang Sun
YCYu Cui
Yu Cui
HFHaiyun Feng
Haiyun Feng
HLHaifeng Liu
Haifeng Liu
XLXiaolong Liu
Xiaolong Liu
Regulatory T (T reg) cells are required for the maintenance of immune homeostasis. Both TGF-β signaling and epigenetic modifications are important for Foxp3 induction, but how TGF-β signaling participates in the epigenetic regulation of Foxp3 remains largely unknown. Here we showed that T cell–specific ablation of Uhrf1 resulted in T reg–biased differentiation in TCR-stimulated naive T cells in the absence of TGF-β signaling, and these Foxp3+ T cells had a suppressive function. Adoptive transfer of Uhrf1−/− naive T cells could significantly suppress colitis due to increased iT reg cell generation. Mechanistically, Uhrf1 was induced upon TCR stimulation and participated in the maintenance of DNA methylation patterns of T reg cell–specific genes during cell division, while it was phosphorylated upon TGF-β stimulation and sequestered outside the nucleus, and ultimately underwent proteasome-dependent degradation. Collectively, our study reveals a novel epigenetic mechanism of TGF-β–mediated iT reg cell differentiation by modulating Uhrf1 activity and suggests that Uhrf1 may be a potential therapeutic target in inflammatory diseases for generating stable iT reg cells.

26 June 2008 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
YZYafeng Zhang
Yafeng Zhang
ZYZhengmin Yang
Zhengmin Yang
YCYonghao Cao
Yonghao Cao
SZShijian Zhang
Shijian Zhang
HLHai Li
Hai Li
XLXiaolong Liu
Xiaolong Liu
Tight control of cell-cycle progression is critical for T-lymphocytes to function properly. Slfn1 (Schlafen1) has been reported to play an important role in the establishment and maintenance of quiescence in T-lymphocytes. However, how Slfn1 accomplishes this critical function remains poorly understood. In the present study, we show that nuclear localization is a prerequisite for Slfn1 to induce cell-cycle arrest, with DnaJB6, identified as a new Slfn1-binding protein, playing a pivotal role in this process. DnaJB6, a chaperone protein of the DnaJ/Hsp (heat-shock protein) 40 family, stabilizes Slfn1 together with its partner Hsp70, and, more importantly, it enhances the nuclear import of Slfn1. Overexpression of DnaJB6 was found to increase Slfn1 nuclear accumulation and resulted in cell-cycle arrest, whereas, in DnaJB6 knock-down cells, Slfn1 was mainly sequestered in the cytoplasm and no cell-cycle arrest was observed. Furthermore, transgenic expression of DnaJB6 in T-lineage cells inhibited Slfn1's degradation, promoted its nuclear import and ultimately led to suppression of T-cell proliferation upon TCR (T-cell receptor) activation. In addition, DnaJB6 increased Slfn1's effect on its downstream target cyclin D1 in co-transfected cells. Altogether, our results demonstrate that DnaJB6 is necessary for translocation of Slfn1 into the nucleus, where Slfn1 down-regulates cyclin D1, induces cell-cycle arrest and programmes a quiescent state of T-cells.

12 December 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JZJingyao Zhao
Jingyao Zhao
XCXufeng Chen
Xufeng Chen
GSGuangrong Song
Guangrong Song
JZJiali Zhang
Jiali Zhang
HLHaifeng Liu
Haifeng Liu
XLXiaolong Liu
Xiaolong Liu
Significance: Hematopoietic stem cells (HSCs) harbor the capacities of both self-renewal and differentiation to sustain life-long production of all blood cells. However, how individual HSCs accomplish the decision of self-renewal versus differentiation remains largely unknown. Here, we find that Uhrf1, a key epigenetic regulator of DNA methylation, specifically controls this critical process. In the absence of Uhrf1, HSCs undergo erythroid-biased differentiation at the expense of self-renewal capacity, leading to hematopoietic failure and lethality. Mechanistically, Uhrf1 regulates the HSC-division mode by DNA methylation-mediated repression of the expression of certain erythroid-specific genes, and thus modulates the cell fate decision of HSCs. This study provides unique insights into the relationship among Uhrf1-mediated DNA methylation, cell-division mode, and HSC fate decision.